State Street® SPDR® S&P Europe Quality Aristocrats UCITS ETF (Acc)

What this fund is

State Street® SPDR® S&P Europe Quality Aristocrats UCITS ETF (Acc) is an exchange-traded fund (ETF) from SPDR, traded under the ticker QPEU (ISIN IE000ZEOCR03). One trade buys a whole basket of holdings, so your money is spread out instead of riding on a single company. In plain terms it is about owning small slices of companies, so you share in their growth when they do well — and their falls when they don't, focused on the European market. It follows the S&P Europe Quality Aristocrats Index index (passive investing): it tracks the market rather than relying on a manager, keeping running costs down, and its largest holdings include Novo Nordisk A/S Class B, ASML Holding NV and Roche Holding Ltd. Spread across roughly 99 holdings (the ten largest ≈ 43%), no one position makes or breaks the fund.

Geographically it leans ~28.2% United Kingdom, ~16.9% Switzerland and ~15.1% France. By industry it concentrates most in ~29.1% Health Care and ~16.1% Industrials. Investors often use a broad fund like this as a long-term 'core' holding — a single building block that covers much of a global portfolio in one trade. Its ongoing charge (TER) is 0.25% a year — about €25 a year on a €10,000 holding, taken automatically from the fund; counting the trading costs inside the fund, the all-in figure is around 0.31%. It is an accumulating share class: dividends are rolled straight back in, compounding your returns rather than landing in your account as cash.

It holds the underlying investments directly (physical replication); it is domiciled in Ireland and UCITS-regulated, a European standard built to protect everyday investors and trades in USD. On the standard KID risk scale it is rated 4 out of 7, which describes how much its price tends to move rather than whether it is good. It launched in 2025, and its KID suggests a holding period of 5 years. As with any investment, its value can go down as well as up, and past performance is not a guide to future results. (Fund data sourced from SPDR.)